Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon to Provide Metabolomic Profiling Services to GSK

NEW YORK (GenomeWeb) – Metabolon today announced a collaboration to provide metabolomic profiling services to GlaxoSmithKline.

The two firms also will collaborate on research projects using Metabolon's DiscoveryHD4 platform. Financial and other terms of the agreement were not disclosed.

GSK will have access to Metabolon's bioinformatics tools, proprietary disease ontologies, and visualization tools to integrate metabolomics data with existing genomics and proteomics data, Metabolon said.

"We believe that embedding metabolomic profiling capabilities at the various stages of R&D is important to enhance the phenotypic 'picture' with the aim of yielding translatable, meaningful results," Metabolon President and CEO John Ryals said in a statement. "Gaps of knowledge can be bridged through the understanding [that] metabolomics provides, which could lead to better targets, higher quality molecules, faster time to the clinic, and reduced risk and cost."

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.